NL7614367A - Farmaceutisch preparaat voor de behandeling van acute of chronische infecties ten gevolge van hepatitis virus b. - Google Patents

Farmaceutisch preparaat voor de behandeling van acute of chronische infecties ten gevolge van hepatitis virus b.

Info

Publication number
NL7614367A
NL7614367A NL7614367A NL7614367A NL7614367A NL 7614367 A NL7614367 A NL 7614367A NL 7614367 A NL7614367 A NL 7614367A NL 7614367 A NL7614367 A NL 7614367A NL 7614367 A NL7614367 A NL 7614367A
Authority
NL
Netherlands
Prior art keywords
acute
treatment
pharmaceutical preparation
hepatitis virus
chronic infections
Prior art date
Application number
NL7614367A
Other languages
English (en)
Dutch (nl)
Original Assignee
Merieux Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merieux Inst filed Critical Merieux Inst
Publication of NL7614367A publication Critical patent/NL7614367A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NL7614367A 1975-12-23 1976-12-23 Farmaceutisch preparaat voor de behandeling van acute of chronische infecties ten gevolge van hepatitis virus b. NL7614367A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7539493A FR2336141A1 (fr) 1975-12-23 1975-12-23 Nouveau medicament permettant de traiter les infections aigues ou chroniques dues au virus de l'hepatite b

Publications (1)

Publication Number Publication Date
NL7614367A true NL7614367A (nl) 1977-06-27

Family

ID=9164075

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7614367A NL7614367A (nl) 1975-12-23 1976-12-23 Farmaceutisch preparaat voor de behandeling van acute of chronische infecties ten gevolge van hepatitis virus b.

Country Status (9)

Country Link
US (1) US4087519A (de)
JP (1) JPS6053009B2 (de)
AT (1) AT360643B (de)
BE (1) BE849615A (de)
CA (1) CA1090701A (de)
DE (1) DE2658170C2 (de)
FR (1) FR2336141A1 (de)
GB (1) GB1569000A (de)
NL (1) NL7614367A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
US4204989A (en) * 1978-12-13 1980-05-27 Merck & Co., Inc. Isolation of hepatitis B e antigen
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
JPS5610119A (en) * 1979-07-05 1981-02-02 Alpha Therapeutic Corp Manufacture of b type hepatitis infection preventive vaccine
US4346073A (en) * 1980-04-11 1982-08-24 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis B immune globulin used to inactivate hepatitis B virus in injectable biological products
JPS60258127A (ja) * 1984-06-04 1985-12-20 Green Cross Corp:The Ｂ型肝炎ワクチンの製造方法
US5274081A (en) * 1989-09-20 1993-12-28 Immuno A.G. Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
US5576175A (en) * 1989-09-20 1996-11-19 Immuno Aktiengesellschaft Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
EP0447984A1 (de) * 1990-03-20 1991-09-25 Abbott Laboratories Hyperimmunglobulin gegen Hepatitis-C-Virus und Verfahren zur Herstellung
US5219578A (en) * 1991-02-25 1993-06-15 Innovet, Inc. Composition and method for immunostimulation in mammals

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2155218A1 (de) * 1970-11-09 1972-09-21 Tokyo Standard Serums, Ltd , Tokio Anti Austrahenantigen Antiserum und Vei fahren zu seiner Herstellung
JPS4948730A (de) * 1972-09-08 1974-05-11

Also Published As

Publication number Publication date
BE849615A (fr) 1977-06-20
CA1090701A (fr) 1980-12-02
US4087519A (en) 1978-05-02
JPS5290620A (en) 1977-07-30
FR2336141B1 (de) 1978-11-03
GB1569000A (en) 1980-06-11
AT360643B (de) 1981-01-26
ATA958876A (de) 1980-06-15
DE2658170A1 (de) 1977-07-07
FR2336141A1 (fr) 1977-07-22
JPS6053009B2 (ja) 1985-11-22
DE2658170C2 (de) 1985-05-15

Similar Documents

Publication Publication Date Title
NL7613094A (nl) Werkwijze voor de continue bereiding van hoogmoleculair polyetheentereftalaat.
NL7613431A (nl) Werkwijze voor de bereiding van o-hydroxybenzal- dehyden.
NL7611599A (nl) Werkwijze voor de continue bereiding van dioc- tylethervrij 2-ethyl-hexylacrylaat.
NL7614367A (nl) Farmaceutisch preparaat voor de behandeling van acute of chronische infecties ten gevolge van hepatitis virus b.
NL7610066A (nl) Werkwijze voor de bereiding van amidoxim deri- vaten.
NL7606994A (nl) Werkwijze voor de bereiding van acylcyaniden.
NL159981B (nl) Werkwijze voor de bereiding van oxabicycloalkenen.
NL7610359A (nl) Werkwijze voor de bereiding van alkenen.
NL7613081A (nl) Werkwijze voor de bereiding van (alpha)-aminoketon derivaat.
NL7604925A (nl) Werkwijze voor de bereiding van formaldehyde.
NL7600512A (nl) Werkwijze voor de bereiding van 2-aminobutanol-1.
NL7609939A (nl) Werkwijze voor de bereiding van n-acylhydroxyaryl- glycinen.
NL7610057A (nl) Werkwijze voor de bereiding van farmaceutische preparaten.
NL7603449A (nl) Werkwijze voor de bereiding van (alpha)-fenylpropion- zuren.
NL7607616A (nl) Werkwijze voor de bereiding van lactonen.
NL184952C (nl) Werkwijze voor de bereiding van cyclohexanonoxim.
NL7607505A (nl) Werkwijze voor de bereiding van sulfamylbenzyl- aminen.
NL7611271A (nl) Werkwijze voor de bereiding van 4-alkylthio- semicarbaziden.
NL7602269A (nl) Werkwijze voor de bereiding van entpolymeren.
NL7602024A (nl) Werkwijze voor de bereiding van aluminiumkomple- xen.
NL7607693A (nl) Werkwijze voor de bereiding van tegen ontste- kingen werkende en bloeddrukverlagende prepara- ten.
NL7605669A (nl) Werkwijze voor de bereiding van lactonen.
NL186160C (nl) Werkwijze voor de bereiding van theaspiran.
NL7607581A (nl) Werkwijze voor de bereiding van polyenen.
NL7600047A (nl) Werkwijze voor het bereiden van farmaceutische preparaten voor het behandelen van storingen van de bloedsomloop.

Legal Events

Date Code Title Description
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed